Navigation Links
Neogen announces 1st quarter results conference call
Date:9/17/2013

LANSING, Mich., Sept. 17, 2013 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announces the following webcast:What:Neogen Corporation 1st quarter results conference callWhen:11 a.m. ET, Tuesday, Sept. 24, 2013Where:http://www.videonewswire.com/event.asp?id=95877How:Live over the Internet — Simply log on to the web at the address above Contact:Terry Maynard, Neogen Corporation, +1-800-234-5333If you are unable to participate during the live webcast, the call will be archived on Neogen's website, www.neogen.com.

Neogen Corporation develops and markets products and services dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, unique proteins, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

 

 

 


'/>"/>
SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neogen launches comprehensive dairy heifer genomic test
2. Neogen announces Bohannon retirement, successor named
3. Neogen launches comprehensive cattle genomic test
4. Neogen reports 27% increase in quarterly net income
5. Neogen launches rapid tests for ractopamine
6. Neogen Corporation Announces 3rd Quarter Results Conference Call
7. Neogen reports 30% increase in quarterly net income
8. Neogen Corporation Announces 1st Quarter Results Conference Call
9. Neogen reports year end results
10. Neogen Corporation Announces Year-End Results Conference Call
11. Neogen acquires Igenity from Merial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Surgical Wound Market with the addition of its newest module, US Hemostats & ... market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
Breaking Biology Technology:
(Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
(Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
Breaking Biology News(10 mins):